MolecularMD Corporation develops and commercializes specialty molecular diagnostics for oncology applications. Its tests are designed to allow appropriate selection, monitoring and management of patients treated with molecularly targeted cancer therapies. MolecularMDs assays incorporate both gold-standard and innovative technologies to provide highly sensitive, standardized, reliable results that support clinical development, regulatory approval, and commercialization of novel anticancer agents. A private company based in Portland, Oregon, MolecularMD was founded by Brian Druker, director of the Knight Cancer Center at Oregon Health & Science University, and Sheridan G. Snyder, entrepreneur and founder of Genzyme Corporation and Upstate Biotechnology.
| Website | http://www.molecularinc.com |
| Revenue | $23.3 million |
| Employees | View employees |
| Address | 314 Academy St, Kelso, Washington 98626, US |
| Phone | +1 360-749-8200 |
| Industry | Commercial & Residential Construction, Construction |
| Competitors | Thermo Fisher Scientific, BD, Merck Group, Agilent Technologies, Illumina, MilliporeSigma, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN, Fisher Scientific +44 more (view full list) |
| SIC | SIC Code 17 Companies, SIC Code 175 Companies |
| NAICS | NAICS Code 238330 Companies, NAICS Code 238 Companies, NAICS Code 2383 Companies, NAICS Code 23833 Companies, NAICS Code 23 Companies |
Looking for a particular Molecular Inc employee's phone or email?
Molecular Inc Questions
The Molecular Inc annual revenue was $23.3 million in 2026.
Molecular Inc is based in Kelso, Washington.
The NAICS codes for Molecular Inc are [238330, 238, 2383, 23833, 23].
The SIC codes for Molecular Inc are [17, 175].
